financetom
Business
financetom
/
Business
/
Sirius XM beats quarterly revenue estimates on steady sports livestreaming demand
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Sirius XM beats quarterly revenue estimates on steady sports livestreaming demand
Jan 30, 2025 5:22 AM

Jan 30 (Reuters) - Audio company Sirius XM

exceeded fourth-quarter revenue estimates on Thursday, driven by

steady demand for its live sports shows, which became popular

over the 2024-2025 NBA season and the inaugural 12-team college

football playoff last year.

The audio entertainment provider is also benefiting from its

partnerships with car manufacturers including Toyota ( TM )

and Lexus by securing in-car access, allowing car buyers to

leverage free trial subscriptions to Sirius XM's satellite radio

services.

The company launched its service in the fourth quarter in

select Tesla and Rivian models, as part of

each company's holiday update.

Sirius XM's self-pay subscribers rose 149,000 in the quarter

ending Dec. 31, compared with a rise of 131,000 a year ago.

Visible Alpha had estimated a 136,780 increase.

Its fourth-quarter churn, which is the rate of customers who

stopped using its services, was 1.5% among self-pay users

compared to 1.6% a year ago, while paid promotional subscribers

declined by 79,000.

Sirius XM reported fourth-quarter revenue of $2.19 billion,

marginally above analysts' average estimate of $2.17 billion,

according to data compiled by LSEG.

Advertising revenue in the reported quarter was $477

million, above analysts' average expectation of $309.7 million.

The company posted a quarterly net profit of $287 million,

compared with $228 million a year earlier.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Equinix Insider Sold Shares Worth $3,900,688, According to a Recent SEC Filing
Equinix Insider Sold Shares Worth $3,900,688, According to a Recent SEC Filing
May 17, 2024
05:52 PM EDT, 05/17/2024 (MT Newswires) -- Brandi Galvin Morandi, Chief Legal and Human Resources Officer, on May 16, 2024, sold 4,870 shares in Equinix ( EQIX ) for $3,900,688. Following the Form 4 filing with the SEC, Morandi has control over a total of 9,958 shares of the company, with 9,958 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1101239/000112760224015905/xslF345X03/form4.xml ...
Zillow Group Insider Sold Shares Worth $726,494, According to a Recent SEC Filing
Zillow Group Insider Sold Shares Worth $726,494, According to a Recent SEC Filing
May 17, 2024
05:51 PM EDT, 05/17/2024 (MT Newswires) -- Jeremy Wacksman, Chief Operating Officer, on May 15, 2024, sold 16,347 shares in Zillow Group ( ZG ) (Z, ZG) for $726,494. Following the Form 4 filing with the SEC, Wacksman has control over a total of 116,926 shares of the company, with 116,926 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1617640/000161764024000072/xslF345X03/wk-form4_1715982392.xml Price: 43.90, Change:...
Zillow Group Insider Sold Shares Worth $476,964, According to a Recent SEC Filing
Zillow Group Insider Sold Shares Worth $476,964, According to a Recent SEC Filing
May 17, 2024
05:56 PM EDT, 05/17/2024 (MT Newswires) -- Dan Spaulding, Chief People Officer, on May 15, 2024, sold 10,756 shares in Zillow Group ( ZG ) (Z, ZG) for $476,964. Following the Form 4 filing with the SEC, Spaulding has control over a total of 73,333 shares of the company, with 73,333 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1617640/000161764024000077/xslF345X03/wk-form4_1715982753.xml Price: 43.90, Change:...
Regeneron Pharmaceuticals Insider Sold Shares Worth $22,355,714, According to a Recent SEC Filing
Regeneron Pharmaceuticals Insider Sold Shares Worth $22,355,714, According to a Recent SEC Filing
May 17, 2024
06:01 PM EDT, 05/17/2024 (MT Newswires) -- Leonard S Schleifer, Director, Board Co-Chair, President & CEO, on May 17, 2024, sold 22,830 shares in Regeneron Pharmaceuticals ( REGN ) for $22,355,714. Following the Form 4 filing with the SEC, Schleifer has control over a total of 695,346 shares of the company, with 466,877 shares held directly and 228,469 controlled indirectly....
Copyright 2023-2026 - www.financetom.com All Rights Reserved